This proposal is to extend the structural studies of the acyl-CoA dehydrogenases and their physiological electron transfer partner, electron transfer flavoprotein (ETF). Acyl-CoA dehydrogenases are a family of enzymes that are involved in the first oxidative step in the mitochondrial catabolism of fatty acids and in the catabolism of some amino acids. ETF funnels the reducing equivalents to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase (ETF-QO), a membrane-bound, iron-sulfur flavoprotein; it is also proposed to determine the structure of ETF-QO. Fatty acid oxidation is the principal energy-yielding process in the liver, kidney, and skeletal muscle. The rate of this process can be altered by diet, physiological status, and disease, exemplified by starvation, pregnancy, and diabetes. The critical roles played in metabolism by acyl-CoA dehydrogenases, ETF, and ETF-QO, is illustrated by the severity of human diseases resulting from inherited deficiencies of each of these enzymes. Crystal structures have been determined for short- and medium-chain acyl-CoA dehydrogenases and their mutants and isovaleryl- and glutaryl-CoA dehydrogenase (GCD). It is proposed: to continue the studies of mutants of MCAD and its complexes with substrate analog/inhibitors; to determine the structure of human long chain acyl-CoA dehydrogenase in order to confirm the catalytic base and determine the structural basis for long-chain specificity; and to complete the refinement of the structure of GCD in order to study the mechanism of the decarboxylation reaction. GCD catalyzes both the dehydrogenation and decarboxylation reactions. Crystal structures of human ETF and a bacterial ETF have been determined. It is proposed to extend these studies to mutant ETFs to study the interactions with their electron transfer partners, the dehydrogenases and ETF-QO. Pig ETF-QO has been crystallized and its structure determination is in progress, using X-ray diffraction methods. The high resolution structure, together with those of ETF and the dehydrogenases, will enable us to study the molecular basis of electron transfer pathway between these flavoproteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM029076-17
Application #
2901982
Study Section
Physical Biochemistry Study Section (PB)
Project Start
1982-03-01
Project End
2003-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
17
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Medical College of Wisconsin
Department
Biochemistry
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Floyd, Brendan J; Wilkerson, Emily M; Veling, Mike T et al. (2016) Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function. Mol Cell 63:621-632
Schiff, Manuel; Haberberger, Birgit; Xia, Chuanwu et al. (2015) Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency. Hum Mol Genet 24:3238-47
Fu, Zhuji; Runquist, Jennifer A; Montgomery, Christa et al. (2010) Functional insights into human HMG-CoA lyase from structures of Acyl-CoA-containing ternary complexes. J Biol Chem 285:26341-9
Gobin-Limballe, Stéphanie; McAndrew, Ryan P; Djouadi, Fatima et al. (2010) Compared effects of missense mutations in Very-Long-Chain Acyl-CoA Dehydrogenase deficiency: Combined analysis by structural, functional and pharmacological approaches. Biochim Biophys Acta 1802:478-84
Fu, Zhuji; Voynova, Natalia E; Herdendorf, Timothy J et al. (2008) Biochemical and structural basis for feedback inhibition of mevalonate kinase and isoprenoid metabolism. Biochemistry 47:3715-24
McAndrew, Ryan P; Wang, Yudong; Mohsen, Al-Walid et al. (2008) Structural basis for substrate fatty acyl chain specificity: crystal structure of human very-long-chain acyl-CoA dehydrogenase. J Biol Chem 283:9435-43
Tu, Xi; Hubbard, Paul A; Kim, Jung-Ja P et al. (2008) Two distinct proton donors at the active site of Escherichia coli 2,4-dienoyl-CoA reductase are responsible for the formation of different products. Biochemistry 47:1167-75
McAndrew, R P; Vockley, J; Kim, J-J P (2008) Molecular basis of dimethylglycine dehydrogenase deficiency associated with pathogenic variant H109R. J Inherit Metab Dis 31:761-8
Rao, K Sudhindra; Fu, Zhuji; Albro, Mark et al. (2007) The effect of a Glu370Asp mutation in glutaryl-CoA dehydrogenase on proton transfer to the dienolate intermediate. Biochemistry 46:14468-77
Gobin-Limballe, S; Djouadi, F; Aubey, F et al. (2007) Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy. Am J Hum Genet 81:1133-43

Showing the most recent 10 out of 44 publications